| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,096 |
3,993 |
$993K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,415 |
6,235 |
$762K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,720 |
2,657 |
$457K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,793 |
1,749 |
$72K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,054 |
1,021 |
$64K |
| G0378 |
Hospital observation service, per hour |
51 |
50 |
$28K |
| 80306 |
|
1,334 |
1,242 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
108 |
108 |
$21K |
| 80053 |
Comprehensive metabolic panel |
2,921 |
2,771 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
809 |
792 |
$19K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,289 |
2,234 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,252 |
4,932 |
$17K |
| 80361 |
|
566 |
527 |
$16K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
246 |
228 |
$15K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
170 |
162 |
$15K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
140 |
137 |
$14K |
| 80050 |
General health panel |
252 |
243 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
183 |
175 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
320 |
311 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,200 |
1,147 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
457 |
433 |
$7K |
| 84484 |
|
774 |
725 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
262 |
256 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
380 |
368 |
$5K |
| 87428 |
|
229 |
227 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
636 |
567 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
398 |
386 |
$4K |
| 80061 |
Lipid panel |
199 |
196 |
$3K |
| 81001 |
|
1,451 |
1,405 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
72 |
66 |
$3K |
| 83690 |
|
753 |
724 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,056 |
977 |
$2K |
| 83735 |
|
443 |
369 |
$2K |
| 81025 |
|
619 |
601 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
238 |
231 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
151 |
149 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
83 |
81 |
$2K |
| 85730 |
|
222 |
210 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
64 |
61 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
177 |
176 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
26 |
26 |
$1K |
| 85610 |
|
293 |
276 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$974.28 |
| 81003 |
|
349 |
330 |
$920.39 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
637 |
595 |
$843.39 |
| 82550 |
|
203 |
190 |
$762.83 |
| 82553 |
|
158 |
146 |
$754.02 |
| 84439 |
|
69 |
68 |
$675.17 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
195 |
194 |
$591.04 |
| 85379 |
|
53 |
51 |
$530.10 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$501.68 |
| 87081 |
|
175 |
173 |
$475.18 |
| 73630 |
|
39 |
38 |
$440.24 |
| 86618 |
|
12 |
12 |
$370.31 |
| 73130 |
|
27 |
27 |
$342.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
509 |
487 |
$340.52 |
| 84145 |
|
17 |
12 |
$314.97 |
| 82077 |
|
24 |
24 |
$262.01 |
| 83880 |
|
12 |
12 |
$253.84 |
| 80320 |
|
18 |
16 |
$197.26 |
| 83605 |
|
24 |
24 |
$176.11 |
| 73110 |
|
12 |
12 |
$150.35 |
| 87186 |
|
14 |
14 |
$122.12 |
| 82948 |
|
54 |
41 |
$105.78 |
| 80076 |
|
15 |
14 |
$101.09 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14 |
13 |
$74.96 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
291 |
280 |
$65.45 |
| 85651 |
|
16 |
14 |
$59.91 |
| 87807 |
|
27 |
27 |
$57.86 |
| 87077 |
|
12 |
12 |
$26.28 |